Pacira(美國(guó))

Pacira Pharmaceuticals

美國(guó)Pacirawww.pacira.com是專注于臨床和商業(yè)發(fā)展的新產(chǎn)品，滿足急性保健醫(yī)生和病人的需求一個(gè)新興的制藥公司。該公司目前的重點(diǎn)是術(shù)后疼痛控制的非阿片類產(chǎn)品的發(fā)展，商業(yè)EXPAREL®（布比卡因注射脂質(zhì)體懸浮液），其主導(dǎo)產(chǎn)品，在2012年4月在美國(guó)推出。EXPAREL和兩個(gè)其他市售產(chǎn)品利用Pacira專有產(chǎn)品交貨技術(shù)DepoFoam®封裝在不改變其分子結(jié)構(gòu)的藥物，然后釋 放超過所需的時(shí)間內(nèi)，一個(gè)獨(dú)特的平臺(tái)。PaciraPharmaceuticals,Inc.(NASDAQ:PCRX)isanemergingspecialtypharmaceuticalcompanyfocusedontheclinicalandcommercialdevelopmentofnewproductsthatmeettheneedsofacutecarepractitionersandtheirpatients.AFocusonPainManagementOurprimaryfocusliesinthedevelopmentofnon-opioidproductsforpostsurgicalpaincontrol.Webelievewehavethetechnologytoimproveproducts'efficacyandsafetyandmakeacriticaldifferencetopatientsintermsofdosingfrequencyandadministration.NowAvailable:EXPAREL®(bupivacaineliposomeinjectablesuspension)isanon-opioidlocalanalgesicindicatedforadministrationintothesurgicalsitetoproducepostsurgicalanalgesia.EXPARELcombines